Before the conference call was announced Cantor Fitzgerald cut...

Before the conference call was announced Cantor Fitzgerald cut their price target, but maintained a BUY rating and "continues to like UNIS' broad portfolio of customized drug delivery systems and recurring revenue model," . They also said that they were puzzeled that Unilife had filed their 8-K and FY 13 financials the Friday before Labor Day with no conference call. It is reasonable to conclude that they now (will have) have something to announce or there would be no reason for the call at all. And with the Morgan Stanley conference the following day it has to be something that they want out before the presentation.

A few days and we will know if Abram was right or if we have a basis for our confidence in Unilife.